Evaluation of Cardiovascular Risk Factors in Incident Dialysis Patients
Recruiting · NCT02813642 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Montpellier
View the official record on ClinicalTrials.gov →Interventions studied
Plasma fibroblast growth factor 23 levelPlasma osteoprotegerin levelVascular calcification score
What this trial is about
To evaluate the relationships between bone mineral markers levels at dialysis start and vascular calcification progression during a 2 year follow up
Who can take part
Age range
18 Years to 90 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patient who has signed the written consent form
- Patient with chronic renal failure starting dialysis therapy
Exclusion criteria
- Pregnancy
- Patient with chronic renal failure not yet on dialysis therapy
Where it is running
5 locations listed.
- Centre Hémodialyse du Lez - Castelnau-le-Lez, France
- AIDER - Montpellier, France
- CHU Montpellier, Nephrology department - Montpellier, France
- CH Nimes, Nephrology department - Nîmes, France
- CH Perpignan, Nephrology department - Perpignan, France